We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $1.52B
1-Year Est. Return 229.41%
This Fund
S&P 500
This Quarter Est. Return
+22.18%
1 Year Est. Return
+229.41%
3 Year Est. Return
+810.62%
5 Year Est. Return
+1,830.01%
10 Year Est. Return
+67,312.86%
AUM
$348M
AUM Growth
+$62.6M
Cap. Flow
+$6.7M
Cap. Flow %
1.92%
Top 10 Hldgs %
43.07%
Holding
103
New
27
Increased
20
Reduced
28
Closed
24

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$12.3M
2
SRPT icon
Sarepta Therapeutics
SRPT
+$4M
3
MZOR
Mazor Robotics Ltd.
MZOR
+$3.63M
4
ALB icon
Albemarle
ALB
+$3.45M
5
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$3.41M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$4.67M
2
ADSK icon
Autodesk
ADSK
+$4.19M
3
MDCO
Medicines Co
MDCO
+$4.13M
4
Z icon
Zillow
Z
+$3.6M
5
SHOP icon
Shopify
SHOP
+$2.96M

Sector Composition

Rank Sector Weight
1 Healthcare 33.64%
2 Miscellaneous 29.96%
3 Communication Services 13.17%
4 Technology 13.06%
5 Consumer Discretionary 5.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QQQ icon
1
PUT
Invesco QQQ Trust
QQQ
$491B
$58.2M 16.71%
400,000
+135,500
+51% +$19.4M
XBI icon
2
PUT
State Street SPDR S&P Biotech ETF
XBI
$11.3B
$21.2M 6.09%
+245,000
New +$19.6M
ALGN icon
3
Align Technology
ALGN
$11B
$13M 3.75%
70,000
-3,000
-4% -$514K
BATRK icon
4
Atlanta Braves Holdings Series B
BATRK
$3.24B
$12.5M 3.59%
495,000
+20,000
+4% +$494K
NFLX icon
5
Netflix
NFLX
$319B
$8.71M 2.5%
480,000
+70,000
+17% +$1.22M
META icon
6
Meta Platforms (Facebook)
META
$1.57T
$8.54M 2.45%
50,000
-3,000
-6% -$501K
ADSK icon
7
Autodesk
ADSK
$44.3B
$8.08M 2.32%
72,000
-38,000
-35% -$4.19M
ISRG icon
8
Intuitive Surgical
ISRG
$124B
$7.84M 2.25%
202,500
+112,500
+125% +$12.3M
RNG icon
9
RingCentral
RNG
$5.92B
$6.01M 1.73%
144,000
-15,700
-10% -$602K
TTWO icon
10
Take-Two Interactive
TTWO
$39.9B
$5.79M 1.66%
56,695
-18,305
-24% -$1.64M
CTLT
11
DELISTED
CATALENT, INC.
CTLT
$5.35M 1.54%
134,000
+51,000
+61% +$1.89M
ABBV icon
12
CALL
AbbVie
ABBV
$444B
$5.33M 1.53%
+60,000
New +$4.57M
ATVI
13
DELISTED
Activision Blizzard
ATVI
$5.1M 1.46%
79,000
+3,000
+4% +$187K
SGI
14
Somnigroup International
SGI
$14.8B
$4.84M 1.39%
300,000
+132,000
+79% +$1.95M
HCA icon
15
PUT
HCA Healthcare
HCA
$87.6B
$4.78M 1.37%
+60,000
New +$4.83M
LKFT
16
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
$4.68M 1.35%
46,000
+28,000
+156% +$2.45M
INGN icon
17
Inogen
INGN
$140M
$4.66M 1.34%
48,946
+27,946
+133% +$2.69M
SRPT icon
18
Sarepta Therapeutics
SRPT
$2.15B
$4.54M 1.3%
+100,000
New +$4M
TWOU
19
DELISTED
2U Inc
TWOU
$4.53M 1.3%
2,694
-293
-10% -$441K
TEAM icon
20
Atlassian
TEAM
$45.7B
$4.32M 1.24%
123,000
+8,000
+7% +$284K
MZOR
21
DELISTED
Mazor Robotics Ltd.
MZOR
$4.29M 1.23%
+87,000
New +$3.63M
AAL icon
22
American Airlines Group
AAL
$8.69B
$4.27M 1.23%
90,000
-31,000
-26% -$1.5M
EXAS
23
DELISTED
Exact Sciences
EXAS
$4.24M 1.22%
90,000
-946
-1% -$38.1K
LOXO
24
DELISTED
Loxo Oncology, Inc
LOXO
$4.14M 1.19%
45,000
+3,000
+7% +$233K
TLND
25
DELISTED
Talend S.A. American Depositary Shares
TLND
$4.09M 1.18%
100,000
+50,000
+100% +$1.93M
1
2 3 4 5

Similar funds

ACM
Adelante Capital Management Alameda, California $1.52B AUM 23.15% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
MIM
Marco Investment Management Atlanta, Georgia $1.52B AUM 47.33% 1-Year Est. Return
RW
RVW Wealth Los Angeles, California $1.52B AUM 23.06% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.52B AUM 3.09% 1-Year Est. Return
WFA
Wellspring Financial Advisors Cleveland, Ohio $1.52B AUM 29.68% 1-Year Est. Return
KCMH
Kontiki Capital Management (HK) Hong Kong $1.52B AUM 10.48% 1-Year Est. Return
SC
Styrax Capital New York $1.52B AUM 57.44% 1-Year Est. Return

Atika Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Atika Capital Management held 103 positions worth $348M, up 22% from $285M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Atika Capital Management's Q3 2017 filing shows 27 new, 20 increased, 28 reduced and 24 closed positions. Its largest new stake was Sarepta Therapeutics: 100,000 shares worth $4.54M. The largest sale was Regeneron Pharmaceuticals, an estimated $4.67M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 33% a quarter earlier, followed by Miscellaneous and Communication Services.

  • Atika Capital Management's largest Q3 2017 buy was Sarepta Therapeutics: 100,000 shares worth $4.54M.
  • Atika Capital Management added most to Intuitive Surgical in Q3 2017, an estimated $12.3M increase.
  • Atika Capital Management's biggest Q3 2017 reduction was Autodesk, cutting an estimated $4.19M.
  • Atika Capital Management fully exited Regeneron Pharmaceuticals in Q3 2017, selling an estimated $4.67M.
  • Atika Capital Management's ten largest holdings make up 43% of its $348M portfolio in Q3 2017.
  • Atika Capital Management opened 27 new positions and closed 24 in Q3 2017.
  • Atika Capital Management's portfolio value rose 22% quarter-over-quarter to $348M.

Based on Atika Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.